ProCE Banner Activity

DAWNING: High Virologic Response Rates at Week 48 With DTG-Based ART Regardless of Baseline NRTI RAMs and Second-Line NRTI Use

Slideset Download
Conference Coverage
In this post-hoc analysis of HIV-infected adults previously failing first-line therapy with NNRTI + 2 NRTIs, HIV-1 RNA < 50 copies/mL was achieved in 82% of DTG recipients with baseline M184V/I and second-line use of 3TC or FTC.

Released: March 13, 2019

Expiration: March 11, 2020

Share

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

This program is supported by independent educational grants from

Gilead

Gilead Text

Janssen

Merck Human Health HIV

ViiV Healthcare